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ABSTRACT

Knee osteoarthritis (knee OA) is the most common type of osteoarthritis (OA) and
accounts for 70% of arthritis-related hospital admissions and 23% of clinical visits. Major
limitations in both the current non-surgical and surgical methods are that they only
relieve pain and show no evidence for restoring natural tissue anatomy. Leaders in the
field propose that a stem cell treatment approach holds promise for the regeneration of a
greater proportion of hyaline-like tissue at the repair site (Cross et al., 2014; Escobar
Ivirico, Bhattacharjee, Kuyinu, Nair, & Laurencin, 2017; Helmick et al., 2008; Toh,
Foldager, Pei, & Hui, 2014).
It is hypothesized that the fate of cells to differentiate toward a specific lineage is
governed by cell-to-cell and cell-to-matrix interactions (Djouad, Mrugala, Noël, &
Jorgensen, 2006). It is necessary to continue the optimization of cell-based biomaterials
for clinically relevant therapies (Gupta PK et al., 2012).
To continue improving cell therapy options applicable to knee OA, decellularized
cartilage from a porcine ear was used as the scaffold for the growth and differentiation of
human cartilage cells. Decellularization techniques have been used to isolate an
extracellular matrix (ECM) scaffold from cells in culture, tissues, or organs. These
previous methods served as the foundation for the similar procedures used in this study.
Results presented by proteomic data showed that the methods used for decellularization
were successful in the removal of cellular components including nuclei, mitochondria,
vi

cytosol, rough endoplasmic reticulum, plasma membrane, and Golgi biomarkers.
Histology and scanning electron microscopy (SEM) show that decellularization resulted
in creating a more porous scaffold. SEM also showed that cells adhered to the surface of
this novel scaffold.
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CHAPTER ONE: INTRODUCTION
Arthritis is defined as inflammation of the joints in the body and has several
different classifications. Osteoarthritis (OA) is the most common type and is defined as a
chronic, debilitating, and painful disease. It is estimated to be one of the leading causes of
disability worldwide (Cross et al., 2014; Escobar Ivirico et al., 2017; Helmick et al.,
2008; Toh et al., 2014).
Sports, recreational activities, and daily movements all can cause cartilage
lesions. Lesions, or chondral defects, left untreated can lead to degenerative joint disease
that may include an inflammatory response (Gupta PK et al., 2012; Toh et al., 2014).
Cartilage in the Knee and Osteoarthritis
Knee osteoarthritis (knee OA) is the most common type of OA and accounts for
70% of arthritis-related hospital admissions and 23% of clinical visits (Escobar Ivirico et
al., 2017), Given its anatomical position the knee, acts as a shock absorber by
withstanding both tension and compression (Goldberg, Mitchell, Soans, Kim, & Zaidi,
2017). Hyaline cartilage within articular joints is located at the ends of long bones.
Cartilage lacks nerve fibers, is avascular, and is composed mostly of water. It is tough,
yet flexible and contains large amounts of glycosaminoglycans (GAGs) such as
chondroitin sulfate and hyaluronic acid (HA), electrostatically bound to type II collagen
fibers. Proteoglycans, such as aggrecan, are predominant molecular constituents of
articular cartilage (Cheng, Solorio, & Alsberg, 2014; Escobar Ivirico et al., 2017; Toh et
al., 2014).
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The precisely organized architecture of the extracellular matrix (ECM) provides
the tissue’s normal structural integrity. The function of the articular cartilage is to protect
the subchondral bone from mechanical forces by distributing the load equally while
maintaining low friction across joint surfaces (Cheng et al., 2014; Escobar Ivirico et al.,
2017; Toh et al., 2014). While normal cartilage supports tissue homeostasis and
chondrocytic differentiation, osteoarthritic cartilage does not effectively carry out the
functions of maintaining cartilage homeostasis and cellular differentiation (Toh et al.,
2014).
Chondroblasts are the predominant cell type in growing cartilage. These cells
produce new ECM until the skeleton stops growing at adolescence. Mature chondrocytes
rarely divide and have limited ability to proliferate. Chondrocytes have been shown to
decrease with age, which may explain why cartilage lesions do not spontaneously heal
(Djouad et al., 2006; Goldberg et al., 2017; Toh et al., 2014). Older adults, above the age
of 50, are at an increased risk for knee OA; this is thought to be due in part to hormonal
changes that cause biological aging in the chondrocytes. Research is currently underway
to better understand why OA is more common in women than men (Escobar Ivirico et al.,
2017).
Articular cartilage degeneration begins at the surface of the bone in the synovial
joint due to the onset of fibrillation, which disrupts the molecular framework of the ECM.
These changes are triggered by mechanical damage or wear and tear of the tissue. The
collagen fibrils disorient beneath the surface, and a decrease in HA and aggrecan have
been reported. Figure 1 highlights the anatomy and structural changes to the knee joint
due to knee OA (Escobar Ivirico et al., 2017; Toh et al., 2014). The blue in the figure
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represents healthy articular cartilage. The red represents progression of cartilage
degradation. When the knee shows no signs of OA, it is classified as stage 0. Stage four,
the final stage is the most severe type of joint damage (Escobar Ivirico et al., 2017).

Figure 1

Structural Changes between a healthy knee joint and an OA knee
(Horizon Pharma)

A better understanding of the cartilage degeneration mechanism could be useful
to help develop new potential treatment strategies to repair damaged cartilage. Currently,
the main treatment option for knee OA is full knee replacement (Escobar Ivirico et al.,
2017).

4

CHAPTER TWO: STEM CELL OPTIONS
Stem cells are undifferentiated, unspecialized cells that can self-renew and may
give rise to one or more specialized cell types (Gupta PK et al., 2012). Cells are thought
to have a common embryonic origin for cellular descendants in the human body. Each
major class of connective tissue has a fundamental cell type that can exist in both a
mature and an immature form (Gupta PK et al., 2012).
Mesenchymal stem cells (MSCs) are the immature form of a chondroblast which
differentiates into a chondrocyte and secretes molecules that form cartilage tissue. MSCs
are multipotent stem cells that can differentiate into multiple cell types. Hyaline is one of
three possible cartilage subclasses: elastic, fibro-, and hyaline. MSCs have a tri-lineage
differentiation capacity, including bone, cartilage, and muscle (Gupta PK et al., 2012;
Olivares-Navarrete et al., 2015).
The multipotential cell capacity of MSCs has enabled doctors to explore using
genetic engineering approaches to grow cartilage within a symptomatic osteochondral
defect. Studies have shown how manipulation of these cells can generate a layer of
hyaline cartilage (Goldberg et al., 2017). Major limitations in both the current nonsurgical and surgical methods, result in relief of pain with no evidence for the restoration
of natural tissue anatomy. It is proposed that an MSC treatment approach could result in a
higher proportion of hyaline-like tissue at the repair site (Escobar Ivirico et al., 2017).
Researchers have developed a wide variety of optimal cell sources for repair, such
as MSC harvested from bone marrow, peripheral blood, adipose tissues, muscle, dermis,
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synovium, umbilical cord blood, placenta, and dental tissues (Djouad et al., 2006;
Escobar Ivirico et al., 2017; Gilpin & Yang, 2017; Gupta PK et al., 2012; Toh et al.,
2014). Bone marrow-derived MSCs are currently used in clinical trial applications for
articular cartilage repair. This cell population has demonstrated potential for
differentiation into chondrocytic cells for cartilage tissue engineering. Studies show an
improved outcome in overall tissue regeneration when cell differentiation is supported, as
indicated by secretion of growth factors and matrix molecules that are characteristic of
cartilage tissue (Toh et al., 2014).
Once an MSC cell source is isolated, it is capable of expansion and expression of
cartilage-specific molecules with or without scaffolds for successful cartilage repair.
Personalized reprogramming by gene and protein factors could lead to new advances in
engineering and regenerative medicine. Current techniques use biomaterials to deliver
MSCs and biological signals to the defect area (Escobar Ivirico et al., 2017; Toh et al.,
2014).
The major limitation in current recellularization approaches through cell therapy
is the formation of fibrocartilage rather than the desired hyaline cartilage. There can also
be cell retention in the target area resulting in the loss of cells, which creates the potential
for cells to move to other parts of the body (Djouad et al., 2006; Escobar Ivirico et al.,
2017; Goldberg et al., 2017). To avoid this issue, it is important to design advance
delivery systems. Biomaterials designed to improve cell adhesion and promote
differentiation that leads to healing in damaged tissue can be used as an alternative
approach for cartilage lesions and OA treatment (Escobar Ivirico et al., 2017; Toh et al.,
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2014). It is necessary to continue the pursuit of improving MSC use for clinicallyrelevant therapies (Gupta PK et al., 2012).
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CHAPTER THREE: DECELLULARIZATION AS A BIOMATERIAL
It is hypothesized that the fate of stem cells as they differentiate toward specific
lineage is governed by the scaffold, specific cell-to-cell and cell-to-matrix interactions
(Djouad et al., 2006; Gilpin & Yang, 2017).
Many studies report the use of various scaffolds to improve maintenance of the
cells inside the defect and the provision of a chondroinductive matrix (Djouad et al.,
2006; Escobar Ivirico et al., 2017; Toh et al., 2014). Besides biocompatibility, the agreed
upon criteria for tissue engineering composites are 1) resorbability, 2) the ability to resist
mechanical stresses, and 3) clinical relevance. Data suggest that scaffolds should support
cell differentiation and maintenance of a mature phenotype when combined with MSCs.
The regeneration of a fully functional tissue will depend on cell density and growth
factors present inside the matrix (Djouad et al., 2006).
Decellularization techniques have been used to isolate a biological ECM from
cells in culture, tissues, or organs. Cellular material that could cause an adverse effect
must be removed (Cheng et al., 2014; Gilpin & Yang, 2017; Toh et al., 2014).
Decellularization methods can be administered to multiple types of tissues (Heath, 2019).
This study will focus on decellularization strategies for cartilage repair.
The ultimate goal of decellularization is to remove all native genetic information
and cellular components from the ECM. All Deoxyribonucleic Acid (DNA) should be
removed, though the structural ECM components must be maintained. A patient’s own
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cells can then be used to repopulate the decellularized ECM through recellularization
(Gilpin & Yang, 2017).
There is no standard decellularization method; however, best practices include
chemical, physical, or combinative methods (Cheng et al., 2014; Gilpin & Yang, 2017;
Heath, 2019; Seon, Marjan, Anthony, & Antonios, 2019). The decellularization process
removes cells and DNA from the tissue while preserving the ECM structural components.
The quality of regenerated tissue for transplantation is measured by the completeness of
removal of cells, total elimination of genetic material, preservation of ECM protein
content, and the retention of mechanical properties of cartilage tissue (Gilpin & Yang,
2017; Xu et al., 2014). Removal of cells and genetic material is the most critical aspect
of the prevention of an immune response and potential transplant rejection (Gilpin &
Yang, 2017).
In this study, decellularization strategies for cartilage were evaluated based on
their ability to remove DNA and other nuclear material while preserving physical and
mechanical properties of the original tissue. A future goal related to this research
investigation is to use cell culture methods on a decellularized matrix to create a
functional tissue for implantation.
Decellularization Strategies
Decellularization is performed using chemical, physical, or combinative methods.
Surfactants, acid and bases, and enzymes make up the chemical and enzymatic portion of
the process. Mechanical agents are also under study to determine if they can decellularize
a tissue or organ. These agents typically work by way of lysing cells through deranging
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the phospholipid bilayer cell membrane. Ionic surfactants are widely used to remove cells
and genetic material (Gilpin & Yang, 2017; Heath, 2019; Seon et al., 2019).
Treatments should be applied with continuous shaking (Elder, Eleswarapu, &
Athanasiou, 2009; Schwarz et al., 2012; Xu et al., 2014). Sodium dodecyl sulfate (SDS)
currently meets the standard requirements of complete cell removal and elimination of at
least 90% DNA. SDS has been shown to damage structural properties if used at high
concentration for long durations (Cheng et al., 2014; Elder et al., 2009; Gilpin & Yang,
2017; Heath, 2019). Five different decellularization treatments showed that several
methods resulted in a significant reduction of DNA. Treatment with 2% SDS for eight
hours resulted in the greatest decrease of DNA; with only minor decreased collagen
content (Cheng et al., 2014; Elder et al., 2009).
Some conflicting information exists regarding the duration of 1% SDS washes.
The time to reach desired decellularization results range from 24 hours to seven days
(Gong et al., 2011; Luo, Eswaramoorthy, Mulhall, & Kelly, 2015). The overall results
indicated that the number of cells could be significantly reduced from engineered
constructs. Higher or lower levels of DNA most likely relates to the thickness of tissue
and the concentration and duration of specific detergents (Elder et al., 2009; Luo et al.,
2015).
Only a few studies have explored decellularization of whole cartilage scaffolds
for joint regeneration. Cartilage is considered immunologically privileged (Luo et al.,
2015; Schwarz et al., 2012). Ethanol (EtOH) can be used to defat samples. Guanidine
hydrochloride and sodium acetate can be used to denature and remove noncollagenous
components (Schwarz et al., 2012). Sodium Hydroxide (NaOH) is recommended to
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inactivate cellular proteins, pathogens, and denature DNA and RNA. NaOH treatment
removes cells and helps increase the porosity of the tissue (Luo et al., 2015; Schwarz et
al., 2012).
Freeze-thaw cycles help to increase the porosity by forming more pores after ice
crystal formation and by killing innate chondrocytes. These cycles are often done in
phosphate-buffered saline (PBS) solution to maintain physiological pH and osmolality,
which additionally helps remove the residual reagents (Cheng et al., 2014; Gilpin &
Yang, 2017; Heath, 2019; Kiyotake, Beck, & Detamore, 2016; Luo et al., 2015; Peretti,
Randolph, & Caruso, 1998; Vas et al., 2018; Xu et al., 2014).
Deoxyribonuclease (DNase) and ribonuclease (RNase) are used to remove DNA
and Ribonucleic acid (RNA). It could take as many as three cycles to exhibit a 95%
decrease in native genetic material (Elder et al., 2009; Gilpin & Yang, 2017; Luo et al.,
2015; Vas et al., 2018; Xu et al., 2014). Removal of 99% of genomic information was
observed after a six day wash cycle (Luo et al., 2015).
Lyophilization has also been shown to help with cell disruption and removal of
cellular components. All samples should be sterilized before proceeding to cell culture
(Rowland, Colucci, & Guilak, 2016; Vas et al., 2018).
Determining the level of Decellularization
Histology is the primary method used to determine if a sample has been
decellularized. Hematoxylin and Eosin (H&E) staining are used to assess construct
cellularity (Elder et al., 2009; Gong et al., 2011; Luo et al., 2015; Schwarz et al., 2012;
Xu et al., 2014). Proteoglycans and GAG deposits can be assessed using Safranin O
staining (Elder et al., 2009; Gong et al., 2011; Xu et al., 2014).

11
A DNA extraction process can be used to quantify the DNA present in cartilage
samples before and after decellularization (Seon et al., 2019; Vas et al., 2018). The DNA
content of the sample can also be measured using a Hoechst assay. DNA present within
the tissue sample will be stained blue (Luo et al., 2015; Seon et al., 2019).
Polymerase chain reaction (PCR) can be used to quantify mRNA expression of
key genes to evaluate the cellular differentiation of the MSCs. PCR is a technique that
amplifies any nucleotide sequence and is highly sensitive to trace amounts of DNA.
Therefore, chondrogenic marker genes can be analyzed for significant changes between
controlled conditions (Pei, Zhang, Li, & Chen, 2012; Vas et al., 2018).
Scanning Electron Microscopy (SEM) is used to visualize the porosity and
surface topology of the decellularized scaffold. SEM can also be used to compare before
and after morphological changes (Gong et al., 2011; Schwarz et al., 2012; Seon et al.,
2019; Xu et al., 2014).
Mass Spectrometry can be used to assess the protein content of the scaffold before
and after decellularization. Additionally, proteomics can be used to monitor the response
of MSCs to the decellularized tissue scaffold. There are limited proteomic studies of
cartilage, which is thought to be due to the difficulty in determining the amount of protein
contribution by cells relative to the total protein contributed by the ECM (Hsueh,
Khabut, Kraus, Biology, & Biology, 2017).
Biomechanical testing is used on samples to monitor ultimate load, stress, and
strain. Load displacement curves are considered to be a straightforward comparison of
tissue strength, which is important for cartilage specimens (Elder et al., 2009; Gilpin &
Yang, 2017; Gong et al., 2011; Luo et al., 2015; Schwarz et al., 2012; Xu et al., 2014).
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Once a tissue sample can be confirmed as decellularized, recellularization of the
scaffold can take place.
Recellularization of a Decellularized Scaffold
As described above, MSCs are seeded onto both sides of a sterile scaffold using
standard cell culture techniques (Goldberg et al., 2017; Gong et al., 2011; Luo et al.,
2015). Sample shapes and sizes vary in each study model. The most common diameter
reported in the literature was 6-millimeter (mm). Sheets were often stacked on top of
each other at different thicknesses ranging from 2 mm to 6 mm (Gong et al., 2011; Luo et
al., 2015). Growth factors may be used during cell culture to improve cell differentiation
(Goldberg et al., 2017; Kiyotake et al., 2016).
The time required for repopulation of scaffolds with cells varies between seven
days to multiple weeks before histological analysis, SEM, biomechanical or other types
of characterization testing can be used. Seeded scaffolds are commonly decellularized
porcine cartilage. Animal trials are ongoing to assess the scaffold’s ability to restore
natural tissue anatomy. Sheets placed in animal joints are being studied to determine
optimal cell density in cell culture (Cheng et al., 2014; Goldberg et al., 2017; Gong et al.,
2011; Peretti et al., 1998). More work on determining cell density before implantation is
recommended. Harvest from the animals typically takes place 12 weeks after
implantation (Cheng et al., 2014; Gong et al., 2011; Kiyotake et al., 2016). However, a
study involving mice with implanted cartilage scaffolds ranged from seven to 42 days
before harvest (Kiyotake et al., 2016; Peretti et al., 1998).
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CHAPTER FOUR: RESEARCH MATERIALS AND METHODS
Materials
Four pig ears were donated from Wakefield Meats in Melba, Idaho. No animals
were harmed in order to perform this research. The pigs were estimated to be one year of
age and adult size.
Dissection Methods
The ears were kept frozen until dissection, which took place one week after the
initial donation by Wakefield Meats. The pig ears were thawed, shaved to remove hair,
and then a scalpel was used to remove all remaining skin without damaging the
underlying cartilage layer. Samples were placed in a 0.5 Molarity (M) NaOH bath
overnight. NaOH is effective at inactivating cellular proteins and pathogens. NaOH can
denature DNA and RNA, remove cells and debris, and has been shown to help increase
porosity by tissue swelling (Luo et al., 2015; Schwarz et al., 2012).
Soft tissue adhering 24 hours later was removed by transfer to a 1.0 M NaOH
solution for three hours followed by transfer to a 70% ethanol solution and incubated at
40 degrees Celsius (˚ C) on a hot plate for three hours. Ethanol was used to remove and to
sterilize soft tissue (Schwarz et al., 2012).
At this time point, the four pig ear cartilage samples were converted into 8 mm
circular discs. Residual decellularized material and twenty 8 mm punches were frozen to
be used for characterization of the cartilage-derived scaffold before decellularization.
These samples were representative of the non-decellularized material.
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Decellularization Methods
The 8 mm cartilage discs underwent a decellularization cycle. A combination of
methods for each wash cycle was determined by previous literature that showed effective
results at removing native cells and DNA content. The first step in the decellularization
process for this study was a solution containing 1 Liter (L) of Deionized Water (DI
water), 1 M guanidine hydrochloride, and 0.05 M sodium acetate. Samples were
incubated on a rocker at 4˚ C for 96 hours. This solution was used to denature and
remove noncollagenous components such as GAGs (Schwarz et al., 2012).
In order to increase porosity and kill innate chondrocytes, the samples were then
subjected to three freeze-thaw cycles in 1% PBS (Cheng et al., 2014; Gilpin & Yang,
2017; Kiyotake et al., 2016; Luo et al., 2015; Peretti et al., 1998; Vas et al., 2018; Xu et
al., 2014).
After the third PBS freeze-thaw cycle, the samples were washed in a solution
containing the following chemicals: 10 Millimolar (mM)
Tris(hydroxymethyl)aminomethane (Tris), 100 Nanomolar (nM) hydrogen chloride
(HCl), 2 mM Ethylenediaminetetraacetic acid (EDTA), 5 mM Magnesium chloride
(MgCl2), 100 mM Dithiothreitol (DTT), 1% SDS, and 1% Triton-X100 with a Power of
Hydrogen (pH) of 8.0. This wash cycle was maintained for 39 hours and took place with
agitation on a rocker at room temperature (22o C). EDTA has been shown to decrease
ECM proteins (Gilpin & Yang, 2017; Luo et al., 2015; Xu et al., 2014). MgCl2 and DTT
facilitate the removal of cell membranes and antigens by increasing the solubility of
proteins (Luo et al., 2015). SDS is widely used in decellularization as it alters the
microstructure of protein and DNA and treatments have resulted in a significant reduction
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in DNA content. SDS concentrations up to 2% Weight/Volume (w/v) have been shown to
decellularize while maintaining the functional properties of tissue scaffolds (Elder et al.,
2009; Gilpin & Yang, 2017; Gong et al., 2011; Luo et al., 2015; Xu et al., 2014). TritonX100 is used for the agglutination of DNA and a decrease in GAG content. Triton-X100
is thought to be less damaging to the structure of tissues (Elder et al., 2009; Gilpin &
Yang, 2017; Luo et al., 2015; Pei et al., 2012).
The third wash step was carried out to remove HA and proteoglycans inside the
cartilage disk (Luo et al., 2015). This mixture consisted of PBS and 21 Units per
Milliliter (U/mL) of hyaluronidase at 37˚ C for 24 hours.
The fourth wash step in the first round of decellularization was a combination of
DNase and RNase to break down DNA and RNA (Gilpin & Yang, 2017; Luo et al.,
2015). This step took place for 24 hours in an incubator held at 37˚ C.
At this stage, histological analysis was carried out on the non-decellularized and
decellularized tissue. Residual cells were identified based on H&E staining. SEM was
also done on the non-decellularized and decellularized tissues at this time point.
Another series of washes were carried out to remove the residual cells. Samples
underwent another freeze-thaw cycle. Samples were allowed to swell for 30 minutes in
DI water. Two percent SDS was then added to the water. Subsequently, samples were
agitated for two hours at 37˚ C. At the end of two hours, the samples were transferred to a
buffered solution of DNase for 72 hours at 37˚ C with agitation. Samples were analyzed
by histology where cells were noted as present. Hoechst staining showed low DNA
content. SEM was also done on this new sample to monitor tissue porosity.
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To remove remaining cells and increase the DNA content removal, one final
series of decellularization wash cycles took place. This series of wash cycles were
identical to those previously described. A major difference was that these wash cycles
took place under constant agitation. At the end of the final wash cycle, a 24-hour
lyophilization cycle was completed. Samples at this time point represent the final
decellularized material. Figure 2 is a flowchart representing a summary of the
decellularization process described. Figure 3 contains information on each wash cycle.

Figure 2

Flowchart of Decellularization
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Figure 3

Key to figure 2, Flowchart of Decellularization

DNA Extraction
Before moving on to recellularization, a DNA extract was done to confirm that
the majority of porcine genomic DNA was removed. A total of three samples were used
for both the non-decellularized material and the decellularized material. The
decellularized samples were rehydrated in 10% PBS. All samples were the same weight
of 0.025 grams (g). Purification of total DNA from the tissue was done with a DNeasy
Kit using the protocol for purification of total DNA from animal tissues (Chomczynski
1987; Fan & Gulley, n.d.).
The tissue was cut up into small pieces and placed in 1.5 mL microcentrifuge
tubes. 180 microliters (µL) of Buffer ATL (SDS Buffer for purification) and 20 µL of
proteinase K, a broad-spectrum serine protease, was added to the tube. The tube was
mixed thoroughly by vortexing. The tube was then incubated at 56oC for one hour to lyse
the cells within the tissue. The tube was again vortexed for 15 seconds. 200 µL of Buffer
AL (Guanidine Hydrochloride and Maleic acid) was added to the sample and mixed
thoroughly by vortexing. 200 µL of ethanol was added to the sample and mixed by
vortexing the tube. The mixture, including precipitate, was moved into the DNeasy Mini
spin column using a pipette. This spin column was placed into a 2 mL collection tube and
centrifuged at 8,000 revolutions per minute (rpm) for one minute. The flow-through and
collection tube was discarded. The DNeasy Mini spin column was placed into a new 2
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mL collection tube. 500 µL of Buffer AW1 (Guanidine Solution) was added to the
sample and was centrifuged for one minute at 8,000 rpm. The flow-through and
collection tube was again discarded. The DNeasy Mini spin column was placed into a
new 2 mL collection tube. 500 µL of Buffer AW2 (Tris-Ethanol Solution) was added to
the sample and was centrifuged for three minutes at 14,000 rpm to dry the DNeasy
membrane. The DNeasy spin column was placed in a clean 1.5 mL microcentrifuge tube.
200 µL of Buffer AE (10mM Tris-HCl and 0.5 mM EDTA, pH 9.0) was added to the
sample. The sample was incubated at room temperature for one minute, then centrifuged
for one minute at 8,000 rpm to elute.
Histology
To visualize the microscopic anatomy of cells and tissues, histology was used.
The cartilage samples were fixed by soaking in 4% paraformaldehyde (PFA) for one hour
then stored in 35% ethanol at 4o C until further processing. Histological processing
consisted of a dehydration embedding program that was 105 minutes. The embedding
process had, as outlined in figure 4, 12 stations. The first seven stations were ethanol
stations at various percentages. Step eight was a 1:1 EtOH:Histoclear station. Stations
nine and ten were 100% Histoclear, followed by stations 11 and 12, which were 100%
paraffin wax.
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Figure 4

Flowchart highlighting the steps in dehydration

After dehydration, the tissue was cut in half and embedded into a block. Figure 5
shows half the tissue placed in a transverse orientation, represented in orange. The other
half was placed in a cross-sectional orientation, represented in blue.

A
B
Figure 5
A.) Example of how Tissue was embedded in Paraffin Wax. Orange
shows transverse orientation and blue represents the cross-sectional. B.) Shows the
actual tissue embedded in a thin sheet of Paraffin Wax
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Figure 5B shows a block sectioned with a sample in transverse and cross-sectional
configuration on a microscope slide. After the slide was prepared, it was stained with
H&E or Alcian Blue. H&E staining detected nucleic acids and endoplasmic reticulum,
indicated by blue stain; and elastic, collagen, and reticular fibers indicated by pink
staining. Alcian Blue is commonly used with cartilaginous tissue as it stains acidic
polysaccharides, such as glycosaminoglycans, and results in a bright greenish-blue color.
Hoechst Evaluation
A slide created from the histology steps described above was dewaxed and
hydrated. After this step, the slide only contained a tissue sample adhered to a glass slide.
This sample was stained with Hoechst stain. Hoechst stain is specific for DNA and
results in a blue stain. A total of 1 µg/mL of Hoechst stain was placed on the sample for
five minutes; it was then rinsed three times with PBS. The samples were imaged on a
Zeiss Confocal LSM 510 Meta microscope.
SEM Preparation and Imaging
All cartilage disks were soaked in 4% PFA for one hour and stored in 35%
ethanol at 4o C until further SEM processing. Samples were then fixed in 2.5%
glutaraldehyde and 1% osmium tetroxide in Nanopure water. After fixation, they were
rinsed in Nanopure water and underwent a dehydration sequence with 50%, 70%, 90%
and 100% ethanol. Critical point drying was performed for ten cycles at 5 °C then
allowed to heat up to 35 °C. Samples were positioned onto an aluminum stub and sealed
by vacuum. Gold sputtering was performed at 0.15 millibar (mbar) and 10 milliamps
(mA) for 15 cycles; 60 seconds sputtering and 60 seconds of rest. Prepped samples were

21
examined at an accelerating voltage of 15 kilovolts (kV) using the secondary electron
detector.
PCR
Two cartilage disks were put in 1mL of Trizol and homogenized using an OMNI
International TH homogenizer. A total of three test tubes, with two cartilage disks pertube, were used. The TRIzol Reagent Isolate DNA procedure was completed before
moving on to the protocol for complementary DNA (cDNA) synthesis using the RT2 First
Strand Kit (RT-RealTime).
The sample was centrifuged for five minutes at 12,000 x g at 4 °C. The clear
supernatant was put in a new tube and incubated for five minutes. The sample was
incubated for an additional two minutes after adding 0.2 mL of Chloroform to the tube.
The sample was then centrifuged for 15 minutes at 12,000 x g at 4 °C. The aqueous phase
containing the RNA was transferred to a new tube.
To continue isolating the RNA, 0.5 mL of Isopropanol was added to the aqueous
phase and incubated for ten minutes. The sample was then centrifuged for ten minutes at
12,000 x g at 4 °C (Qiagen, 2020). At this stage, the supernatant was removed. The pellet
was resuspended in 1 mL of 75% ethanol, vortexed briefly, then centrifuged for five
minutes at 7,500 x g at 4 °C. The supernatant was removed, and the pellet was left to air
dry. Once dry, the pellet was resuspended in 20 µL of RNase-free water and 0.1 mM
EDTA. It was then incubated in a heated block at 55 °C for ten minutes.
At this stage, the DNA yield was determined by measuring the absorbance at 260
nanometers (nm) and 280 nm as described in the protocol for “Purification of Total DNA
from Animal Tissue.” The next step was to follow the protocol for cDNA synthesis using
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the RT2 First Strand Kit. A genomic DNA elimination mix was created using 1.5 µL of
RNA, 2 µL of Buffer GE, and 6.5 µL RNase-free water. This mix was incubated for five
minutes at 42 °C and placed immediately on ice for one minute. A reverse-transcription
mix was created using 4 µL of 5x Buffer BC3, 1 µL Control P2, 2 µL RE3 Reverse
Transcriptase Mix, and 3 µL RNase-free water. The 10 µL reverse-transcription mix was
added to the genomic DNA elimination mix and mixed gently by pipetting up and down.
This mixture was incubated for 15 minutes at 42 °C and then 95 °C for five minutes. At
this stage, 91 µL of RNase-free water was added to the reaction and the Real-Time PCR
array format followed was format F for a 96-well plate.
Following format F instructions, the PCR components mix was 1350 µL of 2x
RT2 SYBR Green Mastermix, 102 µL of cDNA synthesis reaction, and 1248 µL of
RNase-free water. This PCR components mix was loaded into a 96-well plate, 25 µL of
PCR components mix was added to each well using an eight-channel pipettor. Once
filled, the plate was tightly sealed with an adhesive film. The plate was centrifuged for
one minute at 1000 x g at room temperature to remove bubbles. The real-time cycler was
programmed for Roche LightCycler96® conditions. The sample underwent one cycle for
ten minutes at 95 °C and then 45 cycles of 15 seconds at 95 °C and one minute of 60 °C.
Genes analyzed included extracellular matrix proteins, matrix remodeling enzymes, and
cell adhesion molecules. Relative gene expression levels, found by mean plus/minus
standard deviation, were expressed with respect to housekeeping genes determined
empirically for this study.
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Statistical Analysis
Selection of housekeeping genes for qRT-PCR was based on pairwise analysis of
variance for differences between cycle threshold values for five candidate housekeeping
genes from 15 samples within this study. Additionally, correlation analysis was carried
out, data was fit to a trend line, and R2 was determined. Relative expression of genes of
interest was analyzed relative to average values for GAPDH and HPRT, and expressed as
mean plus/minus standard deviation. Log transformed gene expression data was subject
to a paired T-test to determine if the differences in mean values for relative gene
expression were statistically significant, setting significance at p< 0.05.
Proteomics
Two cartilage disks were put in 2 mL of RIPA (Radioimmunoprecipitation assay)
buffer and then homogenized. A total of three test tubes, with two cartilage disks pertube, were used for statistical relevance. The samples were then centrifuged at 14,000 x g
for 15 minutes at 4 ˚C. The lysate and pellet were separated. The lysate was put in a fresh
test tube and frozen at -80 ˚C until further processing.
Proteins from nondecellularized, decellularized, and recellularized scaffolds were
extracted using the RIPA buffer protocol (Millipore, Billerica, MA).
BCA Curve
The total protein concentration of the lysate for all samples was determined via
PierceTM BCA (Bicinchoninic Acid) Protein Assay Kit, Thermo Scientific®. This is a
common method to determine total protein concentration. Once total protein
concentration was determined, samples were submitted for Mass Spectrometry analysis.
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Mass Spectrometry
Twenty micrograms of total protein from each sample were digested with
Trypsin/Lys C mix (Promega, Madison, WI) following the manufacturer’s instruction.
Resulting peptide mixtures were chromatographically separated on a reverse-phase C18
column (10cm x 75µm, 3 µm, 120 Å) and analyzed on a Velos Pro Dual-Pressure Linear
Ion Trap mass spectrometer (Thermo Fisher Scientific).
Peptide spectral matching for porcine and human protein identification were
achieved by database search using Sequest HT algorithms in a Proteome Discoverer 1.4
(Thermo Fisher Scientific). Raw spectrum data were searched against the
UniProtKB/Swiss-Prot protein database for mouse (May 25, 2019). The main search
parameters included: trypsin, maximum missed cleavage site of two, precursor mass
tolerance of 1.5 Da, fragment mass tolerance of 0.8 Da, and variable modification of
oxidation/hydroxylation of methionine, proline, and lysine (+15.995Da). A decoy
database search was performed to calculate a false discovery rate (FDR). Proteins
containing one or more peptides with FDR ≤ 0.05 were considered positively identified
and reported. For all proteins, the total number of peptide spectral matches (PSMs)
reported by the Protein Discoverer 1.4 was used for quantification. To identify newly
synthesized human proteins, the number of PSMs from unique peptides for human
proteins were used for quantification. The mass spectrometry analysis used three samples
at each condition and time point.
Recellularization of the Decellularized Scaffold
Before starting cell culture, the final decellularized cartilage material was
rehydrated in 10% PBS. Once rehydrated, the samples were sanitized by soaking in 70%
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ethanol for 20 minutes. Samples were rinsed three times with PBS and then stored in PBS
for 24 hours at 4 oC. The samples were then put into C28/I2 (Immortalized Human
Chondrocyte) growth media, Dulbecco's Modified Eagle's medium (DMEM) with 10%
Fetal Bovine Serum (FBS) and 1% P/S (penicillin-streptomycin), and stored at 4 oC for
48 hours.
Three 24-well plates were prepared by putting 300 µL of agarose gel at the
bottom of each well to encourage cell adhesion to the decellularized scaffolds. A total of
60 decellularized disks, and four Boise State B shaped cartilage scaffolds were seeded
with 500,000 C28/I2 prechondrocytic mesenchymal stem cells.
C28/I2 cells were put into five tissue culture flasks, and allowed to reach 90%
confluency before seeding onto the scaffolds over ten days of growth. Time points for
characterization took place at one, two, and three weeks. Four samples were collected at
each time point. Samples were incubated in the 24-well plates.
At 48 hours, 500 mL of fresh C28/I2 media was added to each well containing a
sample. On day four, the samples were transferred to new 24-well plates containing the
same amount of agarose gel at the bottom. Samples were kept flat during transfer, and
1000 mL of fresh media was added.
At one week, 1 mL of media and 20 samples were characterized. Subsequent
samples were collected at weeks two and three. The Boise State B scaffolds were
incubated for eight months. Throughout all incubation periods, the media was monitored
and replaced when necessary.
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CHAPTER FIVE: RESULTS AND DISCUSSION
At the end of the ethanol wash during the dissection stage, the cartilage was
considered fully isolated, as shown in figure 6.

Figure 6

Isolated Pig Ear Cartilage

At this time point, the four pig ear cartilage samples were converted into 8 mm
circular punches, as shown in figure 7. The samples were measured in thickness with a
range of 1.44 mm to .74 mm; the average thickness was determined to be 1.08 mm.

Figure 7

Cartilage Disk with an 8mm Diameter

27
To show that these cartilage scaffolds can be made at any size and shape for
patient-specific treatment options, samples were also made into the Boise State
University B as shown in figure 8.

A
Figure 8

B
A) Boise State B. B) Boise State B 8mm Diameter shape made from
original isolated cartilage material

Characterization Before and After Decellularization
DNA Extraction
To confirm that the majority of porcine genomic DNA was removed, genomic
DNA was isolated from the cartilage disks. A total of three samples were used for both
the non-decellularized material and the decellularized material. Purification of total DNA
from the tissue was done using a DNeasy Kit. The protocol used was “Purification of
Total DNA from Animal Tissues” as described in the methods section.
Results from this protocol were obtained by UV-Vis spectroscopy (Nanodrop
spectrometer).
At the end of the first wash cycle, a DNA extract was completed. After
calculating the average of nucleic acid concentration between the three samples, a 75%
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decrease in DNA content using nanograms (ng) per µL was determined as outlined in
table 1.
Table 1
Summary of DNA Extract showing decrease in DNA content after
first wash cycle
Sample

Nucleic Acid

Unit

Sample Type

Non-decellularized material 1

991.8

ng/µl

DNA

Non-decellularized material 2

2974.2

ng/µl

DNA

Non-decellularized material 3

1498.3

ng/µl

DNA

Final decellularized material 1

280.4

ng/µl

DNA

Final decellularized material 2

592.8

ng/µl

DNA

Final decellularized material 3

479.5

ng/µl

DNA

Average non-decellularized
material

1821.43

ng/µl

DNA

Average final decellularized
material

450.9

ng/µl

DNA

Decrease in DNA content

75%

-

DNA

Due to the 75% initial DNA content decrease, it was decided to repeat the wash
cycles using a more aggressive approach. At the end of the final wash cycle, another
DNA extract using the same methods was performed. After calculating the average of
nucleic acid concentration between the three samples, a 92% decrease in DNA content
using nanograms (ng) per µL was determined as outlined in table 2.
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Table 2
Summary of DNA Extract showing decrease in DNA content after
final wash cycle
Sample

Nucleic Acid

Unit

Sample Type

Non-decellularized material 1

33.5

ng/µL

DNA

Non-decellularized material 2

38.7

ng/µL

DNA

Non-decellularized material 3

71.7

ng/µL

DNA

Final decellularized material 1

6.5

ng/µL

DNA

Final decellularized material 2

3.4

ng/µL

DNA

Final decellularized material 3

2.1

ng/µL

DNA

Average non-decellularized
material

47.97

ng/µL

DNA

Average final decellularized
material

4

ng/µL

DNA

Decrease in DNA content

92%

-

DNA

92% decrease in DNA content
60

DNA (ng/uL)

50
40
30
20
10
0

Non-Decellularized

Figure 9

Final Decellularized

DNA Decrease after final wash cycle
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Figure 9 shows the DNA content before and after the decellularization process.
DNA was extracted and quantified spectrophotometrically. Quantitative measurements of
DNA within scaffolds before and after the decellularization process indicated that
residual DNA was at approximately 8% of the original content. Error bars: Mean +/standard error of the mean, N=6.
Proteomic Data
The scaffold was also confirmed to be decellularized using Proteomic data.
Several proteins were present in the non-decellularized scaffold that were not present, or
were depleted by a significant amount in the decellularized scaffold. Removal of cellular
components including nuclei, mitochondria, cytosol, rough endoplasmic reticulum,
plasma membrane and Golgi was measured. Depletion is shown for biomarkers in tables
3 through table 8.
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Table 3

Cellular proteins depleted by decellularization process

Cellular proteins depleted by decellularization process
(nucleus)

%
depletion

Gene
symbol

Aprataxin

100

APTX

BRCA1-A complex subunit RAP80

100

UIMC1

Doublesex- and mab-3-related transcription factor 1

100

DMRT1

Histone H3.3

100

H3F3A

Interferon-induced GTP-binding protein Mx1

100

MX1

Interferon-stimulated gene 20 kDa protein

100

Isg20

Iron-responsive element-binding protein 2

100

IREB2

Myocardin

100

MYOCD

Nuclear factor of activated T-cells, cytoplasmic 1

100

NFATC1

Nuclear receptor subfamily 0 group B member 1

100

NR0B1

Polypyrimidine tract-binding protein 1

100

PTBP1

POU domain, class 5, transcription factor 1

100

POU5F1

Sorbin and SH3 domain-containing protein 2

100

SORBS2

SRSF protein kinase 3

100

SRPK3

Sterol regulatory element-binding protein 1

100

SREBF1

Histone H4

96

Histone
H4

Signal transducer and activator of transcription 5A

89

STAT5A

Hepatocyte nuclear factor 1-beta

85

HNF1B

Pre-mRNA-splicing factor ATP-dependent RNA helicase
DHX16

85

DHX16

V(D)J recombination-activating protein 1

83

RAG1
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It was anticipated to obtain 100% removal of DNA after the decellularization
treatment. It was surprising this was not the case. Even after the procedure was repeated
it did not reduce the DNA content to zero percent. Additional characterization using
mass spectrometry to analyze the content of the scaffold before and after treatment of
decellularization was carried out. Nuclear proteins were considered potential suitable
biomarkers for decellularization. A profile of 20 nuclear proteins was investigated that
included APTX, UIMC1, DMRT1, H3F3A, MX1, ISG20, IREB2, MYOCD, NFATC1,
NROB1, PTBP1, POU5F, SORBS2, SRPK3, SREBF1, HISTONE H4, STAT5A,
HNF1B, DHX16, and RAG1. Of these, 15 were depleted to a level that rendered them no
longer detectable by mass spectrometry. Five of these (HISTONE H4, STAT5A, HNF1B,
DHX16, and RAG1) were depleted by 83 – 96%, indicating that there may be
biochemical interactions mediating molecular interactions independent of the cellular
compartment. This study has identified a nuclear protein profile of 15 proteins that could
be used in the future to assess the efficiency of the decellularization process. The nuclear
proteins comprising this profile are listed in table 3.
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Table 4

Mitochondrial proteins depleted by decellularization process
Mitochondrial proteins

%
depletion

Gene
symbol

Aconitate hydratase, mitochondrial

100

ACO2

A-kinase anchor protein 10, mitochondrial

100

AKAP10

Aspartate aminotransferase, mitochondrial

100

GOT2

Carnitine O-palmitoyltransferase 1, muscle isoform

100

CPT1B

Cholesterol side-chain cleavage enzyme, mitochondrial

100

CYP11A1

Cysteine protease ATG4D

100

ATG4D

Cytochrome b-245 heavy chain

100

CYBB

Cytochrome c oxidase copper chaperone

100

COX17

Cytochrome P450 11B1, mitochondrial

100

CYP11B1

Glycerol-3-phosphate acyltransferase 1, mitochondrial

100

GPAM

Glycine amidinotransferase, mitochondrial

100

GATM

Methylmalonyl-CoA mutase, mitochondrial

100

MUT

Mitochondrial Rho GTPase 2

100

RHOT2

Mitochondrial uncoupling protein 2

100

UCP2

Mitochondrial uncoupling protein 3

100

UCP3

NADH-ubiquinone oxidoreductase chain 5

100

MT-ND5

Succinate dehydrogenase [ubiquinone] flavoprotein subunit,
mitochondrial

100

SDHA

Succinate--CoA ligase [ADP/GDP-forming] subunit alpha,
mitochondrial

100

SUCLG1

Valine--tRNA ligase, mitochondrial

100

VARS2

Amine oxidase [flavin-containing] B

91

MAOB

Mitochondria-eating protein

91

SPATA18
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Nicotinamide phosphoribosyltransferase

91

NAMPT

Hexokinase-2 OS=Sus scrofa

87

HK2

Kynurenine 3-monooxygenase

85

KMO

NADP-dependent malic enzyme

83

ME1

Cytochrome P450 3A29

78

CYP3A29

Glyceraldehyde-3-phosphate dehydrogenase

66

GAPDH

Hydroxymethylglutaryl-CoA synthase, mitochondrial

66

HMGCS2

Creatine kinase U-type, mitochondrial

55

CKMT1

Mitochondrial proteins were also investigated to determine a protein profile of
mitochondrial biomarkers that may serve as a reference set to provide more reliable
indicators of decellularization. The protein content of 29 mitochondrial proteins was
measured, and 19 of these (ACO2, AKAP10, GOT2, CPT1B, CYP11A1, ATC4D,
CYBB, COX17, CYP11B1, GPAM, GATM, MUT, RHOT2, UCP2, UCP3, MT-ND5,
SDHA, CUCLG1, and VARS2) were efficiently depleted through the decellularization
process. In contrast, some mitochondrial proteins were detected after the decellularization
process, indicating that they may not be reliable indicators of decellularization.
Mitochondrial proteins and their extent of depletion are listed in table 4.
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Table 5

Cytosolic proteins depleted by decellularization process
%
depletio
n

Gene
symbol

1-acylglycerol-3-phosphate O-acyltransferase ABHD5

100

ABHD5

4-hydroxyphenylpyruvate dioxygenase

100

HPD

Actin, cytoplasmic 1

100

ACTB

Alcohol dehydrogenase [NADP(+)]

100

AKR1A
1

Antileukoproteinase

100

SLPI

ATP-dependent 6-phosphofructokinase, muscle type

100

PFKM

Autophagy protein 5

100

ATG5

Bifunctional epoxide hydrolase 2

100

EPHX2

Biogenesis of lysosome-related organelles complex 1 subunit 5

100

BLOC1
S5

Calponin-1 OS

100

CNN1

Calponin-2

100

CNN2

Cas scaffolding protein family member 4

100

CASS4

Coatomer subunit beta

100

COPB1

Diacylglycerol kinase alpha

100

DGKA

Dihydropyrimidine dehydrogenase [NADP(+)]

100

DPYD

FAST kinase domain-containing protein 4

100

TBRG4

Gastrotropin

100

FABP6

Growth factor receptor-bound protein 10

100

Grb10

Integrin beta-1-binding protein 2

100

ITGB1B
P2

L-dopachrome tautomerase

100

DCT

Cytosolic proteins
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L-lactate dehydrogenase A chain

100

LDHA

Myosin light chain 4

100

MYL4

Myosin-1

100

MYH1

Myosin-2

100

MYH2

Nucleoside diphosphate kinase B

100

NME2

Perilipin-3

100

PLIN3

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit
gamma isoform

100

PIK3CG

Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A
beta isoform

100

PPP2R1
B

Suppressor of cytokine signaling 2

100

SOCS2

Thimet oligopeptidase

100

THOP1

Triosephosphate isomerase

100

TPI1

Tubulin alpha-1A chain

100

TUBA1
A

Tubulin beta chain

100

TUBB

Vinculin

100

VCL

Serine/threonine-protein kinase WNK1

95

WNK1

L-lactate dehydrogenase B chain

94

LDHB

UTP--glucose-1-phosphate uridylyltransferase

92

UGP2

Eukaryotic initiation factor 4A-III

89

EIF4A3

Triokinase/FMN cyclase

85

TKFC

Acylphosphatase-1

83

ACYP1

Glycine N-methyltransferase

78

GNMT

N-acetylneuraminate lyase

78

NPL

Phosphatidylinositol 3-kinase catalytic subunit type 3

78

PIK3C3

37

Serine/threonine-protein phosphatase 1 regulatory subunit 10

64

PPP1R1
0

Cytosolic proteins were also investigated to determine a protein profile of
cytosolic biomarkers that may serve as a reference set to provide further reliable
indicators of decellularization. The protein content of 44 cytosolic proteins was
measured, and 34 of these (ABHD5, HPD, ACTB, AKR1A1, SLPI, PFKM, ATG5,
EPHX2, BLOC1S5, CNN1, CNN2, CASS4, COPB1, DGKA, DPYD, TBRG4, FABP6,
Grb10, ITGB1BP2, DCT, LDHA, MYL4, MYH1, MYH2, NME2, PLIN3, PIK3CG,
PPP2R1B, SOCS2, THOP1, TPI1, TUBA1A, TUBB, and VCL) were efficiently depleted
through the decellularization process. In contrast, some cytosolic proteins were detected
after the decellularization process, indicating that they may not be reliable indicators of
decellularization. Cytosolic proteins and their extent of depletion are listed in table 5.
A total of 65 membrane proteins were investigated to analyze the extent to which
they were depleted during the decellularization process. Of these, 38 membrane proteins
(ARF6, ALOX15, CAPN1, CXCR4, CYSLTR2, DSG1, EDNRA, GJA1, RABGGTA,
GGT1, GHR, GNAQ, ITGB1, IFNAR1, IL4R, IL6R, LDLR, KIT, STEAP1, NTRK3,
PTH1R, PDZD11, ATP2B1, PECAM1, PCDH11X, RAMP1, SAG, SIGLEC1, SLADQCA, SLA-DQCB, SLA-DQDB, KCNN3, SLC5A1, SLC22A6, SLC22A7, TPO,
TLR9, and TGFBR3) were determined to serve as reliable indicators of decellularization.
Membrane protein biomarkers that may serve as suitable indicators of cellular depletion
are listed in table 6.
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Table 6

Membrane proteins depleted by decellularization process
Membrane proteins

%
depletion

Gene
symbol

ADP-ribosylation factor 6

100

ARF6

Arachidonate 15-lipoxygenase

100

ALOX15

Calpain-1 catalytic subunit

100

CAPN1

C-X-C chemokine receptor type 4

100

CXCR4

Cysteinyl leukotriene receptor 2

100

CYSLTR2

Desmoglein-1

100

DSG1

Endothelin-1 receptor

100

EDNRA

Gap junction alpha-1 protein

100

GJA1

Geranylgeranyl transferase type-2 subunit alpha

100

RABGGTA

Glutathione hydrolase 1 proenzyme

100

GGT1

Growth hormone receptor

100

GHR

Guanine nucleotide-binding protein G(q) subunit alpha

100

GNAQ

Integrin beta-1

100

ITGB1

Interferon alpha/beta receptor 1

100

IFNAR1

Interleukin-4 receptor subunit alpha

100

IL4R

Interleukin-6 receptor subunit alpha

100

IL6R

Low-density lipoprotein receptor

100

LDLR

Mast/stem cell growth factor receptor Kit

100

KIT

Metalloreductase STEAP1

100

STEAP1

NT-3 growth factor receptor

100

NTRK3

Parathyroid hormone/parathyroid hormone-related peptide
receptor

100

PTH1R
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PDZ domain-containing protein 11

100

PDZD11

Plasma membrane calcium-transporting ATPase 1

100

ATP2B1

Platelet endothelial cell adhesion molecule

100

PECAM1

Protocadherin-11 X-linked

100

PCDH11X

Receptor activity-modifying protein 1

100

RAMP1

S-arrestin

100

SAG

Sialoadhesin

100

SIGLEC1

SLA class II histocompatibility antigen, DQ haplotype C alpha
chain

100

SLA-DQCA

SLA class II histocompatibility antigen, DQ haplotype C beta
chain

100

SLA-DQCB

SLA class II histocompatibility antigen, DQ haplotype D beta
chain

100

SLA-DQDB

Small conductance calcium-activated potassium channel protein 3

100

KCNN3

Sodium/glucose cotransporter 1

100

SLC5A1

Solute carrier family 22 member 6

100

SLC22A6

Solute carrier family 22 member 7

100

SLC22A7

Thyroid peroxidase

100

TPO

Toll-like receptor 9

100

TLR9

Transforming growth factor beta receptor type 3

100

TGFBR3

Beta-1 adrenergic receptor

94

ADRB1

Zonadhesin

94

ZAN

Glutathione S-transferase alpha M14

94

GSTAM14

Activin receptor type-2B

93

ACVR2B

Solute carrier family 22 member 1

91

SLC22A1

Low-density lipoprotein receptor-related protein 2

89

LRP2
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Orexin receptor type 2

89

HCRTR2

Glutamate decarboxylase 2

89

GAD2

Ectonucleotide pyrophosphatase/phosphodiesterase family
member 6

85

ENPP6

Tyrosine-protein kinase SYK

85

SYK

Hormone-sensitive lipase

85

LIPE

V-type proton ATPase catalytic subunit A

85

ATP6V1A

Potassium-transporting ATPase alpha chain 1

82

ATP4A

Electrogenic sodium bicarbonate cotransporter 1

81

SLC4A4

Alpha-2A adrenergic receptor

78

ADRA2A

Calcium-activated chloride channel regulator 1

78

CLCA1

Gastrin/cholecystokinin type B receptor

78

CCKBR

Hepatocyte growth factor receptor

78

MET

Leptin receptor

78

LEPR

Extracellular calcium-sensing receptor

70

CASR

Scavenger receptor class B member 1

70

SCARB1

ATP-binding cassette sub-family G member 2

66

ABCG2

Major facilitator superfamily domain-containing protein 6

66

MFSD6

H(+)/Cl(-) exchange transporter 5

63

CLCN5

Prolactin receptor

55

PRLR

Beta-3 adrenergic receptor

55

ADRB3

Lutropin-choriogonadotropic hormone receptor

55

LHCGR

Endoplasmic reticulum proteins were investigated by mass spectrometry before
and after decellularization. A protein profile comprising 16 endoplasmic reticulum
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proteins may be considered as reliable biomarkers for the decellularization process
(RPS13, RPS3, CYP8B1, RPL14, RPL6, CRYBB1, RPN2, HSPA5, FOLH1, HSPA1A,
HSPA1B, HSPA1L, HMOX1, GANAB, ATP2A2, and VCP). Mass spectrometry
detected other endoplasmic reticulum proteins that were not as efficiently removed from
tissue by the decellularization process. These may indicate non-specific interactions and
render them as unreliable indicators of decellularization. Endoplasmic reticulum proteins
and the extent to which they were depleted during the decellularization process are listed
in table 7.
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Table 7

Endoplasmic reticulum depleted by decellularization process
Endoplasmic reticulum

%
depletion

Gene
symbol

40S ribosomal protein S13

100

RPS13

40S ribosomal protein S3

100

RPS3

5-beta-cholestane-3-alpha,7-alpha-diol 12-alpha-hydroxylase

100

CYP8B1

60S ribosomal protein L14

100

RPL14

60S ribosomal protein L6

100

RPL6

Beta-crystallin B1

100

CRYBB1

Dolichyl-diphosphooligosaccharide--protein glycosyltransferase
subunit 2

100

RPN2

Endoplasmic reticulum chaperone BiP

100

HSPA5

Glutamate carboxypeptidase 2

100

FOLH1

Heat shock 70 kDa protein 1A

100

HSPA1A

Heat shock 70 kDa protein 1B

100

HSPA1B

Heat shock 70 kDa protein 1-like

100

HSPA1L

Heme oxygenase 1

100

HMOX1

Neutral alpha-glucosidase AB

100

GANAB

Sarcoplasmic/endoplasmic reticulum calcium ATPase 2

100

ATP2A2

Transitional endoplasmic reticulum ATPase

100

VCP

Microsomal triglyceride transfer protein large subunit

85

MTTP

Dolichyl-diphosphooligosaccharide--protein glycosyltransferase
subunit 1

78

RPN1

Dual oxidase 1

78

DUOX1

Heat shock protein HSP 90-alpha

78

HSP90AA1
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Organelle cellular proteins were also analyzed, including those associated with
mitochondria, Golgi, and endoplasmic reticulum. Five Golgi-specific proteins, 29
mitochondrial proteins, and 20 endoplasmic reticulum proteins were depleted as a result
of the decellularization process. It was determined that Golgi proteins B3GALNT1,
MAN1A1, FUT2, and MGAT4C represent a protein profile that may be suitable to
monitor cellular depletion during decellularization processes. However, the Golgi protein
B3GNT5 was not fully depleted in this experiment, potentially due to secondary
interactions. Golgi proteins and the extent to which depletion was observed are listed in
table 8.
Table 8

Golgi proteins depleted by decellularization process
Golgi

%
depletion

Gene
symbol

UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1

100

B3GALNT1

Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA

100

MAN1A1

Galactoside 2-alpha-L-fucosyltransferase 2

100

FUT2

Alpha-1,3-mannosyl-glycoprotein 4-beta-Nacetylglucosaminyltransferase C

100

MGAT4C

Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase
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B3GNT5

Retention of Extracellular Matrix Proteins in the resulting Decellularized Scaffold
The purpose of decellularization was to remove cellular content while preserving
the structural proteins of the extracellular matrix. Nine noncollagenous extracellular
matrix proteins were analyzed by mass spectrometry before and after decellularization.
Of these, FMOD, DAG1, FBN1, ACAN, and DCN were depleted to levels below the
limit of detection. Noncollagenous ECM proteins were partially retained in the
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decellularized scaffold and may contribute to the successful recellularization process.
These include MFGE8, HAPLN1, TNC, and BGN. Noncollagenous proteins and their
extent of depletion are shown in table 9.
Table 9
Extracellular matrix noncollagenous proteins depleted by
decellularization process
Extracellular matrix noncollagenous
proteins

%
depleted

Gene
symbol

Fibromodulin

100

FMOD

Dystroglycan

100

DAG1

Fibrillin-1

100

FBN1

Aggrecan core protein

100

ACAN

Decorin

100

DCN

Lactadherin

98

MFGE8

Hyaluronan and proteoglycan link protein
1

90

HAPLN1

Tenascin

70

TNC

Biglycan
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BGN

39 collagen alpha chains were analyzed before and after decellularization to
assess collagenous composition of the resulting decellularized scaffold. The collagen
alpha chains were detected in native cartilage by mass spectrometry. After the
decellularization process, nine of these were no longer detectable. Blue bars show
composition of cartilage before the decellularization process, and red bars show
composition of the scaffold after the decellularization process. The resulting
decellularized scaffold comprised predominantly of COL2A1, COL1A1, COL6A1,
COL1A2, COL11A1, COL11A2, COL3A1, COL5A1, COL5A2, COL5A3, COL4A5,
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COL4A2, and COL4A3. Minor contributions of COL7A1, COL16A1, COL22A1,
COL27A1, COL28A1, COL12A1, COL13A1, COL14A1, and COL17A1 were detected
after decellularization, as shown in figure 10.

COL2A1
COL6A3
COL11A2
COL4A5
COL7A1
COL16A1
COL4A2
COL4A3
COL5A3
COL10A1
COL4A4
COL4A1
COL8A1
COL6A2
COL8A2
COL21A1
COL17A1
COL6A6
COL20A1
COL15A1

Figure 10

Composition of cartilage before (blue) and after (red)
decellularization
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Future work should aim to better understand each of these proteins functions and
how it relates to cartilage.
Histology
In order to visualize the microscopic anatomy of cells and tissues, histology was
used. figure 11 shows the non-decellularized porcine cartilage before processing with an
H&E Stain.

Figure 11

H&E Stain on Non-Decellularized Cartilage. 10x Transverse Image,
with a scale bar of 100 μm

Figure 12 shows the final decellularized H&E stain.
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Figure 12

H&E Stain on Final Decellularized Cartilage. 10x Transverse Image,
with a scale bar of 100 μm

Figure 13 shows the final decellularized Alcian Blue stain. Alcian Blue stain was
not noticeably detectable in the non-decellularized cartilage.
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Figure 13

Alcian Blue Stain on Final Decellularized Cartilage. 10x Transverse
Image, with a scale bar of 100 μm

Histological analysis showed a decrease in cellular structures, with the
preservation of the extracellular collagen fiber networks.
Hoechst Evaluation
Hoechst stain is specific for DNA and results in a blue stain. The samples were
imaged on a Zeiss Confocal LSM 510 Meta microscope. The Hoechst stain images, as
shown in figure 14, confirmed that DNA was removed as a result of the decellularization
wash cycles.
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A
Figure 14

B
Hoechst Stain at 40x, with a scale bar of 50 μm. A) Non-Decellularized
Sample. B) Decellularized Sample

SEM Preparation and Imaging
SEM confirmed that the decellularization wash cycles successfully resulted in
making the scaffold more porous. The collagen fibers of the ECM were isolated during
the process. The surface of a non-decellularized cartilage disc is shown in figure 15 with
a scale bar of 20 µm.
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Figure 15

Non-Decellularized Cartilage Disk. Scale bar of 20µm

Figure 16 shows the final decellularized cartilage discs surface with a scale bar of
20 µm.
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Figure 16

Final Decellularized Cartilage Disk. Scale bar of 20µm
Characterization After Recellularization

Histology
Samples were processed the same way as described for the non-decellularized and
decellularized samples. The cellular samples were imaged at weeks one, two, and three
after seeding with C28/I2 cells. The Boise State B scaffolds were imaged at the end of
their eight-month incubation period. Figure 17 shows the recellularized Boise State B
Cartilage Sample with C28/I2 cells in both the Alcian Blue Stain and H&E Stain.
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Figure 17

Recellularized Boise State B Cartilage Sample with Alcian Blue Stain
at 20x, with a scale bar of 50 μm
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Figure 18

Recellularized Boise State B Cartilage Sample with H&E Stain at 20x,
with a scale bar of 50 μm

SEM Imaging
Samples were processed the same way as described for the non-decellularized and
decellularized samples. The cellular samples were imaged at weeks one, two, and three
after seeding with the C28/I2 cells. The Boise State B scaffolds were imaged at the end of
their eight-month incubation period. Figure 19 shows cells adhering to the cellular
scaffold in week one.
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Figure 19

Recellularized Cartilage Disk with C28/I2 Cells at week 1. Scale bar of
20µm

Figure 20 shows bundles of cells on the recellularized Boise State B scaffolds at
the eight-month time point.
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Figure 20

Recellularized Boise State B shaped Cartilage Disk with C28/I2 Cells
at 8 months. Scale bar of 20µm

These SEM images showed that overtime the cells did proliferate on the surface
of the scaffold. They formed clusters of cells in various places among the collagen fibers
in comparison to individual cells, as shown in week one images. There was very little
change in comparison of week one, two, and three time points.
Characterization of Cellular Response to the Scaffolds
In order to understand the cellular response during recellularization, a molecular
biology approach was used. Real-time quantitative PCR was used. As a control, cells
were also grown on tissue culture (TC) plastic under standard culture conditions to
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evaluate cellular responses and to determine if the decellularized scaffold helps influence
chondrogenesis.

Q-RT-PCR
Selection of housekeeping genes
Five candidate housekeeping genes, as listed in table 10, were compared for all
experimental conditions used in this study to identify those that remain constant and,
therefore, may serve as appropriate housekeeping genes controls. GAPDH and HPRT
were selected as the housekeeping gene for normalization in these experiments based on
comparison to three other candidate housekeeping genes; both were found to be stably
expressed independently of experimental conditions based on minimum variance.
Correlation analysis confirmed that GAPDH and HPRT expression levels are correlated
throughout the experiments, as demonstrated in figure 21.

Table 10

Housekeeping genes

ACTB
B2M
GAP
DH
HPRT
1
RPLP
0

87.4
9
140.
54
135.
44
125.
96
ACTB M

10.
77
9.0
1
7.3
4
B2

 0.11
1.49
GAP
DH

0.91
HPR
T1

RPL
P0
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HPRT1

HPRT1 - GAPDH correlation

y = 0.792x + 9.8279
R² = 0.8711

GAPDH

Figure 21

HPRT1 - GAPDH correlation

Comparison of Scaffold versus Plastic
Relative abundance of genes associated with chondrogenesis was calculated and
reported here as mean plus/minus standard deviation. As shown in figure 22, gene
expression is induced under control chondrogenic conditions on tissue culture plastic,
indicated by data points above the diagonal line (figure 22). In figure 23, the diagonal
line indicates the trend expected if there is no difference between the cellular response
when cells are grown on the cartilage scaffold versus grown on tissue culture plastic.
Data points above the line reflect genes expressed at higher levels on the cartilage
scaffold compared to plastic. Data points below the line indicate genes that are expressed
at higher levels on plastic compared to the cartilage scaffold. Data points that fall on the
line were not changed (figure 23).
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Day 7 on Plastic

Increase in gene expression during chondrogenesis on TC
plastic

Day 0 on Plastic

Figure 22

Increase in gene expression during chondrogenesis on TC plastic

C28/I2 at 7 days on Scaffold

Cartilage scaffold supports more robust gene expression than
TC plastic

C28/I2 at 7 days on Plastic

Figure 23

Cartilage scaffold supports more robust gene expression than TC
plastic
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A total of 76 genes were analyzed during chondrocyte differentiation for seven
days. A total of 52 genes were upregulated during seven days of chondrocyte
differentiation on standard TC plastic (figure 22). Of those 52 genes, 33 genes in cells
cultured on decellularized 3-D (three-dimensional) porcine scaffold showed an increase
in expression. A total of 19 genes were upregulated on tissue culture plastic during
chondrogenesis; but, were not upregulated significantly during the same period by cells
cultured on decellularized porcine cartilage scaffold. A total of 25 genes were
upregulated during chondrogenesis on the cartilage scaffold that was not observed to be
upregulated on tissue culture plastic under standard 2-D (two-dimensional) culture
conditions (figure 23).
Of the genes unique to the scaffold not seen on TC plastic, the protein functions
were investigated and summarized in table 11.
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Table 11
Chondrogenic markers expressed by chondrocytes that are enhanced
by growth on the scaffold not seen on TC plastic and their function
Genes Unique to Scaffold not seen on TC Plastic
Gene
symbol

Name

Function
Provides instruction for making a
protein called epithelial cadherin,
which is found in the membrane that
surrounds epithelial cells. This
family of proteins functions to help
neighboring cells stick together to
form organized tissues. Cell
Adhesion.

CDH1

Cadherin-1

CLEC3B

C-type lectin
Encodes for a protein called
domain family 3, Tetranectin. Cellular response to
member B
transforming growth factor stimulus.

Reference

(Tomschy,
Fauser,
Landwehr, &
Engel, 1996)

(Mazzoni et
al., n.d., 2019)

Collagen, type
XII, alpha 1

Encodes for the alpha chain of type
XII collagen. Modifies the
interactions between Collagen fibrils
and the surrounding matrix. A
component of Cartilage ECM.

(Agarwal et al.,
2012)

Collagen, type
XV, alpha 1

Encodes the alpha chain of type XV
collagen. Strongest expression in
basement membrane zones may
function to adhere basement
membranes to underlying connective
tissue.

(Karlsson et
al., 2010)

CTGF

Connective
tissue growth
factor

Modulates signaling pathways
leading to cell adhesion and
migration, along with ECM
deposition and remodeling, which
together lead to tissue remodeling.

(Lipson,
Wong, Teng,
& Spong,
2012)

CTNND1

Catenin
(cadherinassociated
protein), delta 1

Functions in adhesion between cells
and signal transduction. Helps
regulate the maintenance of the
superficial zone of Articular
cartilage.

(Taniguchi et
al., 2009)

COL12A1

COL15A1
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Extracellular
matrix protein 1

Inhibits chondrocyte hypertrophy,
matrix mineralization, and
endochondral bone formation.

(Kong et al.,
2010)

ICAM1

Intercellular
adhesion
molecule 1

Encodes a cell surface glycoprotein,
which is typically expressed on
endothelial cells and cells of the
immune system. On the surface of
osteoblasts, and might also be
involved in the regulation of joint
diseases.

(Rangkasenee
et al., 2020)

ITGA3

Integrin, alpha 3
(antigen CD49C,
Involved in cell adhesion and
alpha 3 subunit
collagen binding.
of VLA-3
receptor)

(Zhang &
Zhang, 2019)

ITGA4

Integrin, alpha 4
(antigen CD49D, Functions in cell surface adhesion
alpha 4 subunit
and signaling, ECM receptor
of VLA-4
interaction.
receptor)

(Zhu et al.,
2017)

ECM1

ITGA6

Integrin, alpha 6

Functions in cell surface adhesion
and signaling.

(Lapointe,
Verpoorte, &
Stevens, 2013;
Tu et al., 2020)

ITGAM

Integrin, alpha
M (complement
component 3
receptor 3
subunit)

Cell adhesion-related molecules.

(Wang et al.,
2019)

ITGB3

Integrin, beta 3
(platelet
glycoprotein
IIIa, antigen
CD61)

Participates in cell adhesion as well
as cell surface-mediated signaling.

(Fabiana N.
Soki, Ryu
Yoshida, 2018)

Integrin, beta 5

Cell surface receptors that participate
in cell adhesion as well as cell
(Adapala &
surface-mediated signaling.
Kim, 2016)
Remodeling component for articular
cartilage.

ITGB5
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KAL1
(Anos1)

Anosmin 1

Found in zones of articular cartilage
ECM, Cell Surface Protein.

(Grogan et al.,
2014)

LAMA1

Laminin, alpha 1

Major component of the basement
membrane. Associated with cell
adhesion, differentiation, migration,
and signaling.

(Mann et al.,
2019)

MMP10

Matrix
metallopeptidase
10 (stromelysin
2)

Involved in the breakdown of
extracellular matrix in normal
physiological processes, such as
tissue remodeling.

(Proteomics,
Of, To, &
Injury, 2018)

MMP12

Matrix
metallopeptidase
12

Involved in the breakdown of
extracellular matrix in normal
physiological processes, such as
tissue remodeling.

(Lv et al.,
2016)

MMP9

Matrix
metallopeptidase
9 (gelatinase B,
92kDa
gelatinase,
92kDa type IV
collagenase)

Involved in the breakdown of
extracellular matrix in normal
physiological processes, such as
tissue remodeling.

(Miao et al.,
2004)

SELP

Selectin P
(granule
membrane
protein 140kDa,
antigen CD62)

This protein redistributes to the
plasma membrane during platelet
activation and degranulation.

(Gari et al.,
2016)

SGCE

Sarcoglycan,
epsilon

Links the actin cytoskeleton to the
ECM.

(Rouillard et
al., 2016)

SPG7

Spastic
paraplegia 7
(pure and
complicated
autosomal
recessive)

Roles in diverse cellular processes
including membrane trafficking,
intracellular motility, organelle
biogenesis, protein folding, and
proteolysis.

(Bonn,
Pantakani,
Shoukier,
Langer, &
Mannan, 2010)

THBS3

Mediates cell-to-cell and cell-toThrombospondin
matrix interactions. Found in
3
developing cartilage.

(Hankenson,
Hormuzdi,
Meganck, &
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Bornstein,
2005)

VCAN

Versican

Major component of the ECM;
involved in cell adhesion and
proliferation during chondrogenesis.

VTN

Vitronectin

ECM markers that promote cell
adhesion and spreading.

(Sztrolovics et
al., 2002)
(Vieira et al.,
2015)

Markers of Chondrogenesis detected by Mass Spectrometry after growth on
Decellularized Scaffold
Figure 24 summarizes the results of proteomic analysis after recellularization of
the decellularized scaffold.

Collagen Content Increase (Δ% and ΔPSM)
0

100

200

300

400

500

600

COL3A1
COL4A4

% increase

COL22A1

PSM increase

COL9A3
COL4A2
COL5A2
COL12A1
COL27A1
COL7A1
COL24A1
COL18A1
COL4A6
COL2A1
0.00

2.00

Figure 24

4.00

6.00

8.00

10.00

12.00

Percent Change of Collagen Content

14.00

64

CHAPTER SIX: CONCLUSIONS AND FUTURE WORK
To our knowledge, this study represents the first demonstration of biomarkers for
decellularization of a Porcine ear for cartilage regeneration. After dissecting a Porcine ear
to isolate the cartilage, a series of four wash cycles took place to remove unwanted
cellular materials. The Sodium Acetate and Guanidine Hydrochloride wash were to
denature and remove noncollagenous components. The SDS, Tris, HCL, EDTA, MgCl2,
DTT, and Triton-X wash were to decrease ECM proteins, alter the microstructure of
collagen fibers, and cause agglutination of DNA. The Hyaluronidase wash was to remove
HA and proteoglycan inside the cartilage disk. The DNase and RNase wash were to break
down DNA and RNA, followed by a freeze-thaw cycle to increase porosity. Freeze-thaw
cycles in between wash cycles were to increase porosity and kill innate chondrocytes.
Data compiled includes results from DNA extraction, a Hoechst evaluation,
Histology, SEM, Mass spectrometry, and PCR. It was concluded that the
decellularization wash cycles successfully resulted in decellularizing the porcine cartilage
scaffold. Traditionally, laboratories have monitored DNA content to determine if cells
have been removed since all cells contain DNA. However, there may be false-positive
signals for DNA that does not indicate that cells are still present. Therefore, additional
components were analyzed of cells, and mass spectrometry was used to measure the
removal of cellular components including nuclei, mitochondria, cytosol, rough
endoplasmic reticulum, plasma membrane, and Golgi. These additional measures showed
that the cells were removed below the threshold of detection.
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A more aggressive decellularization wash cycle could have been used in the
beginning to avoid repeating wash cycles. Future work could be done to monitor
component changes at each level of decellularization. At the end of decellularization in
this experiment, a 92 % decrease was observed between the non-decellularized material
and the final decellularized material. The 8% of material left behind is thought to be
because of the biochemistry within the ECM. These remaining materials could be
“sticky,”; therefore, the proteins are determined not fully depleted after decellularization
and would not qualify as sufficient markers. Previous work has not fully analyzed what is
left behind after decellularization. Future work should be done to better understand the
material left behind after decellularization as it is important when evaluating laboratorygenerated cartilage for patient-specific biocompatibility.
The scaffold was shown to be more porous after decellularization in both SEM
and Histology when compared to its original material. Visual cell components present in
the non-decellularized histology images were not shown in the decellularized images. No
cells were shown to be present in histology images after the decellularized scaffolds were
recellularized. Future work could be done using a binding protein to increase cell
proliferation inside the scaffold. Future work could also consider looking at if cells are
needed inside the scaffold. Mechanical testing was not done in this experiment but should
be done to understand the strength of these cartilage disks in comparison to healthy
human cartilage.
It is not recommended to do media changes so early in cell culture. Adding fresh
media only, could prevent cells loosely adhered to the surface of the scaffold from being
lost during incubation periods. SEM images showed cells could attach and proliferate on
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the surface of the scaffold. The cells also express genes, as shown in PCR and Proteomic
data.
The collagen fibers of the ECM were isolated during the process. To characterize
the scaffold remaining after decellularization, collagens present by mass spectrometry
were analyzed. Thirty-nine collagen alpha chains were detected in native cartilage by
mass spectrometry. After the decellularization process, nine of these were no longer
detectable.
This study is novel because it looks at new knowledge by analyzing proteins that
make up the decellularized porcine tissue and the recellularized scaffold. It provides
insight on acceptable markers for decellularization by looking at a profile of markers
instead of just one or two proteins. The use of other cell lines could benefit this field of
research by using patient-specific MSC’s or pre-chondrocytes. A major limitation of this
study was also that it mainly looked at short term changes. The scaffolds grown up to
eight months showed an increase in cellular adhesion and proliferation. Future
experiments in cell culture should be longer in duration.
Overall, this novel research shows promise that laboratory-generated cartilage
could be a future alternative treatment option for individuals suffering from OA. These
cartilage discs can be made to fit any cartilage lesion. This approach aims to restore the
patient’s natural anatomy and prevent the need of a joint replacement. Using
decellularization to create biomaterials can generate biocompatible scaffolds. Patientspecific chondrocytes can promote differentiation that in the long term is predicted to
lead to healing damaged tissue.
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